Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer

Lucía Taja‐Chayeb(Instituto Nacional de Cancerología), Alfonso Dueñas‐González(Instituto Nacional de Cancerología)

Cancer Cell International

October 2, 2006

10.1186/1475-2867-6-22

Cited by 35

Related Papers

Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix

|Journal of Clinical Oncology|2011|479

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

|Oncology Letters|2020|16